Orly Leiva
Impact in
- Internal Medicine top 2%
- Venous Thromboembolism Diagnosis and Management
- Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
-
- Venous Thromboembolism Diagnosis and Management 13
- Genetics 32
- Myeloproliferative Neoplasms: Diagnosis and Treatment 31
- Co-authors
- Jean M. ConnorsKatya RavidGabriela HobbsHanny Al‐SamkariChristopher P. CannonDeepak L. BhattRuth B. MorrisonSamuel Z. Goldhaber
- Journals
- Blood (8 papers)JACC CardioOncology (4 papers)Circulation (4 papers)Current Treatment Options in Oncology (3 papers)Research and Practice in Thrombosis and Haemostasis (2 papers)
- Partner nations
- United StatesSpainNetherlands
In The Last Decade
Orly Leiva
64 papers receiving 893 citations
Peers
Comparison fields: 5 of 80
- Internal Medicine 203
- Genetics 249
- Hematology 216
- Cardiology and Cardiovascular Medicine 254
- Rheumatology 158
Countries citing papers authored by Orly Leiva
This map shows the geographic impact of Orly Leiva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Orly Leiva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Orly Leiva more than expected).
Fields of papers citing papers by Orly Leiva
This network shows the impact of papers produced by Orly Leiva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Orly Leiva. The network helps show where Orly Leiva may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Orly Leiva, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 6 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 4 | |
| 9 | 2023 | 5 | |
| 10 | 2023 | 9 | |
| 11 | 2023 | 6 | |
| 12 | 2022 | 23 | |
| 13 | 2022 | 11 | |
| 14 | 2021 | 19 | |
| 15 | 2020 | 13 | |
| 16 | 2020 | 33 | |
| 17 | 2020 | 1 | |
| 18 | 2020 | 22 | |
| 19 | 2020 | 32 | |
| 20 | 2020 | 1 |
About Orly Leiva
Orly Leiva is a scholar working on Internal Medicine, Genetics, Hematology, Rheumatology and Cardiology and Cardiovascular Medicine, having authored 70 papers that have together received 906 indexed citations. Recurring topics across this work include Myeloproliferative Neoplasms: Diagnosis and Treatment (31 papers), Eosinophilic Disorders and Syndromes (23 papers), Venous Thromboembolism Diagnosis and Management (13 papers), Chronic Myeloid Leukemia Treatments (12 papers), Chemotherapy-induced cardiotoxicity and mitigation (8 papers), Acute Myocardial Infarction Research (6 papers), Kruppel-like factors research (6 papers) and Cardiac Structural Anomalies and Repair (5 papers). The work is most often cited by research in Internal Medicine (203 citations), Genetics (249 citations), Hematology (216 citations), Cardiology and Cardiovascular Medicine (254 citations) and Rheumatology (158 citations). Orly Leiva has collaborated with scholars based in United States, Spain and Netherlands. Frequent co-authors include Jean M. Connors, Katya Ravid, Gabriela Hobbs, Hanny Al‐Samkari, Christopher P. Cannon, Deepak L. Bhatt, Ruth B. Morrison, Samuel Z. Goldhaber, Gregory Piazza and Zaid Almarzooq. Their work appears in journals such as Blood, JACC CardioOncology, Circulation, Current Treatment Options in Oncology and Research and Practice in Thrombosis and Haemostasis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.